LON:CIZ Cizzle Biotechnology (CIZ) Share Price, News & Analysis GBX 1.60 +0.05 (+3.23%) (As of 09/6/2024 ET) Add Share Share Today's Range 1.50▼ 1.6850-Day Range 1.52▼ 2.2352-Week Range 1.42▼ 3.38Volume968,365 shsAverage Volume1.37 million shsMarket Capitalization£6.34 millionAssets Under Management£48.98 millionDividend Yield3.45%Net Expense Ratio0.46% Stock AnalysisStock AnalysisChartDividendHoldingsStock AnalysisChartDividendHoldings Get Cizzle Biotechnology alerts: Email Address About Cizzle Biotechnology (LON:CIZ)Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.Read More CIZ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CIZ ETF News HeadlinesApril 26, 2024 | wsj.comCizzle Biotechnology Holdings PLCJanuary 6, 2024 | finance.yahoo.comCizzle Biotechnology Holdings Plc (CIZ.L)September 7, 2024 | Golden Crest (Ad)Biden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.August 15, 2023 | lse.co.ukMurphy Canyon to hold meeting on planned buy of interest in AZD1656August 10, 2023 | lse.co.ukTRADING UPDATES: Aterian granted 10 exploration licences in MoroccoJuly 18, 2023 | bizjournals.comPhiladelphia Biotech NewsJuly 16, 2023 | investing.comCizzle Biotechnology Holdings PLC (CIZ)June 12, 2023 | lse.co.ukCizzle subscription raises GBP350,000 to fund development pipelineSeptember 7, 2024 | Golden Crest (Ad)Biden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.June 12, 2023 | marketwatch.comCizzle Biotechnology Raises GBP350,000 via SubscriptionSee More Headlines Receive CIZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cizzle Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerVictory Capital Management Fund NameVictoryShares Developed Enhanced Volatility Wtd ETF Tax ClassificationRegulated Investment Company Stock ExchangeLONCurrent SymbolLON:CIZ Inception Date9/30/2014 Fund ManagerMannik Dhillon, Stephen Hammers Webwww.cizzlebiotechnology.com Phone44-20-3934-6630Fund Focus Asset ClassEquity BenchmarkNasdaq Victory?International 500 Long/Cash Volatility Weighted Index CategorySize and Style FocusLarge Cap Development LevelDeveloped Markets RegionGlobal Ex-U.S. Number of Holdings505 Fund Statistics Assets Under Management$48.98 million Average Daily Volume$9,243.20 Discount/Premium0.17% Administrator, Advisor and Custodian AdministratorVictory Capital Management Inc. AdvisorVictory Capital Management Inc. CustodianCitibank, N.A. DistributorForeside Fund Services, LLC Transfer AgentCitibank, N.A. TrusteeN/A Lead Market MakerRBC Capital Markets Options OptionableN/A Short Interest15,600 shs Miscellaneous Outstanding Shares396,390,000Beta0.36 Creation Unit50,000 Creation Fee$4,500.00 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade Cizzle Biotechnology ExpensesTypeCIZLarge Cap ETFsEquity ETFsLON ETFsAll ETFsManagement Fee0.40%0.57%0.55%0.45%0.52%Other Expenses0.25%0.30%0.49%0.25%0.54%Total Expense0.66%0.64%0.71%0.54%0.71%Fee Waiver-0.20%-0.25%-0.53%-0.20%-0.58%Net Expense0.46%0.61%0.61%0.47%0.59% Cizzle Biotechnology (CIZ) Holdings & ExposureTop 10 CIZ HoldingsKoninklijke KPN NVHolding Weight: 0.46%London Stock Exchange Group plcHolding Weight: 0.41%Deutsche Telekom AGHolding Weight: 0.40%Unilever PLCHolding Weight: 0.39%Oversea-Chinese Banking Corporation LimitedHolding Weight: 0.38%Zurich Insurance Group AGHolding Weight: 0.38%DBS Group Holdings LtdHolding Weight: 0.37%GeneraliHolding Weight: 0.36%Royal Bank of CanadaHolding Weight: 0.36%Commonwealth Bank of AustraliaHolding Weight: 0.35%CIZ Sector ExposureCIZ Industry ExposureFull Holdings Details Key ExecutivesMr. Allan John Syms (Age 68)Executive Chairman Prof. Dawn Coverley (Age 59)Founder, Chief Scientific Officer & Non-Executive Director Mr. Nigel R. Lee (Age 63)Finance Director & Executive Director Mr. Morgan WilliamsHead of Commercialisation for Yorkshire Cancer Research and Board Observer CIZ ETF - Frequently Asked Questions How have CIZ shares performed this year? Cizzle Biotechnology's stock was trading at GBX 1.95 on January 1st, 2024. Since then, CIZ shares have decreased by 17.9% and is now trading at GBX 1.60. View the best growth stocks for 2024 here. How do I buy shares of Cizzle Biotechnology? Shares of CIZ stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:CIZ) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cizzle Biotechnology Holdings Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cizzle Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.